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Abstract 
Objective: The multifunctional NS1 protein of influenza A virus has roles in antagonising cellular innate immune 
responses and promoting viral gene expression. To better understand the interplay between these functions, we 
tested the effects of NS1 effector domain mutations known to affect homo-dimerisation or interactions with cellular 
PI3 kinase or Trim25 on NS1 ability to promote nuclear export of viral mRNAs.
Results: The NS1 dimerisation mutant W187R retained the functions of binding cellular NXF1 as well as stabilising 
NXF1 interaction with viral segment 7 mRNAs and promoting their nuclear export. Two PI3K-binding mutants, NS1 
Y89F and Y89A still bound NXF1 but no longer promoted NXF1 interactions with segment 7 mRNA or its nuclear 
export. The Trim25-binding mutant NS1 E96A/E97A bound NXF1 and supported NXF1 interactions with segment 7 
mRNA but no longer supported mRNA nuclear export. Analysis of WT and mutant NS1 interaction partners identi-
fied hsp70 as specifically binding to NS1 E96A/E97A. Whilst these data suggest the possibility of functional links 
between NS1’s effects on intracellular signalling and its role in viral mRNA nuclear export, they also indicate potential 
pleiotropic effects of the NS1 mutations; in the case of E96A/E97A possibly via disrupted protein folding leading to 
chaperone recruitment.
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Introduction
Influenza A virus (IAV) infects both man and animals, 
including species important for food security [1]. A better 
understanding of its replication cycle is important to aid 
control measures. Like all viruses, IAV co-opts multiple 
cellular systems for replication and also has to counter-
act innate immune defence mechanisms. A key virally-
encoded factor in both processes is the NS1 protein. As 
a nuclear-replicating virus, IAV utilises the nuclear RNA 
export factor 1 (NXF1) cellular mRNA export pathway to 
direct several of its mRNAs to the cytoplasm [2] and we 
and others have recently found that NS1 acts as an adap-
tor between segment 7 mRNAs (encoding the M1 or M2 
proteins) and cellular mRNA processing/export pathways 
[3, 4]. NS1 is also the primary viral antagonist of innate 
immune responses, interfering with the function of mul-
tiple cellular polypeptides including protein kinase R, 
2′-5′-oligoadenylate synthase, cleavage and polyadenyla-
tion specificity factor (CPSF) 30 and tripartite motif-
containing protein 25 (Trim25) [5]. NS1 also activates 
the phosphoinositide 3-kinase (PI3K) complex, possi-
bly to inhibit apoptosis [6]. Structurally, NS1 consists of 
an N-terminal RNA-binding domain and a C-terminal 
“effector” domain followed by a disordered tail, with no 
identified enzymatic activities. Instead, it functions by 
binding to multiple different proteins and RNAs (viral 
and cellular) and altering their activities [5]. Various NS1 
point mutations have been identified that inhibit these 
interactions and comparative analyses of the behaviour 
of wild type (WT) and mutant IAV strains with these 
alterations have provided important information on the 
biological significance of each particular function. Here, 
we tested whether mutations identified as affecting NS1 
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interactions with the p85ß subunit of PI3K (Y89A and 
Y89F), Trim25 (E96A/E97A) and NS1 effector domain-
mediated oligomerisation (W187R) [7–11] also affected 




All IAV plasmid constructs and viruses were based on 
the A/PR/8/34 (PR8) strain described previously [12]. 
NS1 mutations used in this study were introduced by 
standard PCR mutagenesis reactions; primer sequences 
are available on request. Methods for virus reverse genet-
ics, infection, minireplicon assays, fluorescent in  situ 
hybridization (FISH), immunofluorescence and confocal 
microscopy, green fluorescent protein (GFP)-trap pull-
downs, western blots and reverse transcriptase-radioac-
tive primer extension are described elsewhere [4]. Liquid 
chromatography–mass spectrometry (LC–MS) analysis 
was performed using a RSLCnano system (Thermo Fisher 
Scientific) coupled to a micrOTOF QII mass spectrom-
eter (Bruker) on in-gel trypsin digested protein bands 
excised from Coomassie Blue-stained SDS-PAGE gels 
[13]. Raw spectral data were processed to peak lists 
and searched using Mascot 2.4 server (Matrix Science) 
against the Uniprot Human sequence database contain-
ing 93,786 entries.
Results
Our previous work led to the hypothesis of NS1 acting 
as an adaptor protein to feed viral segment 7 mRNA(s) 
into the cellular NXF1 export pathway, by forming a ter-
nary complex between NS1, NXF1 and the mRNA that 
requires both the NS1 effector domain and a functional 
RNA-binding domain [4]. To further test the role of the 
NS1 effector domain, a set of point mutations in this 
region of the protein were tested (Table 1), firstly in a sub-
viral “minireplicon” system. 293T cells were transfected 
with plasmids to produce segment 7 ribonucleoproteins 
(RNPs) as well as with either WT or mutant NS1s as 
GFP-fusion proteins. Cells were fixed 24 h post transfec-
tion and segment 7 mRNA localisation detected by FISH 
(Fig. 1a). NS1 expression was confirmed by detection of 
GFP signal as well as by western blot, although the E96A/
E97A mutant accumulated to lower levels than the other 
NS1s (Fig. 1b). WT NS1-GFP and most mutant proteins 
localised largely to the cytoplasm, but the W187R mutant 
was found both in nucleus and cytoplasm (Fig.  1a). No 
mRNA staining was detected in the negative control 
lacking a complete RNP. As expected [4], when the mini-
mal components for RNP reconstitution were present, 
Table 1 Genetic and phenotypic summary of the NS1 polypeptides used in this study
a Stop codon added at position 82
b See [4] for experimental data
NS1 protein mRNA export NXF1 binding M1 mRNA binding Functional alteration References
WT + + + N/A [12]
N81a,b − − − Effector domain deletion [14]
R38A/K41Ab − − − dsRNA-binding [15]
F103S/M106Ib + + + Gain of CPSF inhibition [16]
Y89A − + − PI3K-binding [17]
Y89F − + − PI3K-binding [8]
E96A/97A − + + Trim25-binding [9]
W187R + + + Homo-dimerisation [11]
(See figure on next page.)
Fig. 1 Effect of mutations in the NS1 effector domain on segment 7 mRNA localisation. a–c 293T cells were transfected with plasmids to recreate 
segment 7 RNPs or, as a negative control with a combination that excluded a plasmid expressing PB2 (2PNP), together with the indicated NS1-GFP 
polypeptides. a Cells were processed for FISH analysis at 24 h post transfection (p.t.) using Cy3-labelled RNA probes for detection of positive sense 
segment 7 viral RNAs (red). GFP fluorescence was also detected (green). Images were captured using a Leica-TCS confocal microscope and Leica TCS 
analysis software. b Duplicate cell samples were lysed and examined by SDS-PAGE and western blotting for GFP and tubulin. c Individual cells were 
scored according to the predominant cellular localisation of segment 7 mRNA considering three phenotypes: nuclear, cytoplasmic or mixed. Values 
are the mean ± range from two independent experiments. A 2-way ANOVA was used to test for statistically significant differences between the 
values for each category from those obtained for WT-NS1 (NS, not significant; ****p < 0.0001). d 293T cells were mock infected or infected with the 
indicated viruses at an M.O.I. of 5. At 6 h post infection (p.i.), cells were processed for FISH as above (red) and stained with anti-NS1 serum (green) 
and DAPI (for DNA; blue). Scale-bars indicate 10 µm. Lanes 1 and 2 in b and a portion of the corresponding numerical data in c are taken with 
permission from Figure 4b, c respectively of [4]
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segment 7 mRNA was detected primarily in cell nuclei, 
whilst on addition of NS1-GFP, it translocated to the 
cytoplasm. However, in the presence of PI3K-binding 
mutants NS1-Y89A and NS1-Y89F or the Trim25-binding 
mutant NS1-E96A/E97A, segment 7 mRNA was clearly 
still retained in the nucleus. In contrast, the dimerization 
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mutant NS1-W187R caused segment 7 mRNA to local-
ise to the cytoplasm. To quantify these effects, cells were 
visually scored according to the predominant cellular 
localisation of segment 7 mRNA (nuclear, cytoplasmic 
or both). In the absence of NS1, segment 7 was mainly 
nuclear in ~ 80% of cells scored, while the remaining cells 
presented mRNA staining both in the nucleus and the 
cytoplasm (Fig. 1c). When WT NS1 or NS1-W187R were 
added, a statistically significant shift of segment 7 mRNA 
localisation was confirmed, with ~ 75% of cells show-
ing mRNA in the cytoplasm. However, addition of NS1-
E96A/E97A, NS1-Y89A or NS1-Y89F did not produce 
this shift, with a clear majority of cells displaying nuclear 
segment 7 mRNA, similarly to samples with no NS1-GFP. 
To further test the mRNA export activity of the NS1 
effector domain mutants, their phenotype was examined 
in the context of virus infection. 293T cells were mock 
infected or infected with either WT PR8 or the NS1 
mutant viruses and at 6 h post infection (p.i.), fixed and 
processed for segment 7 FISH analysis as well as immu-
nofluorescently stained for NS1 (Fig. 1d). All viruses gen-
erally gave cytoplasmic NS1 signal above the uninfected 
cell background, although staining of cells infected with 
NS1-Y89 and NS1-E96A/E97A mutants was notice-
ably fainter than the WT and W187R viruses. No viral 
mRNA signal was detected in the mock sample while 
segment 7 mRNA was cytoplasmic in WT and W187R 
virus-infected cells. In cells infected with NS1-Y89A, 
NS1-Y89F and NS1-E96A/E97A, segment 7 mRNA was 
predominantly nuclear. Thus, in both minireplicon and 
viral settings, the NS1 dimerization mutant W187R sup-
ported normal segment 7 mRNA nuclear export, but 
the PI3K-binding and Trim25-binding mutants showed 
loss-of-function.
NS1 both binds NXF1 and promotes the ability of 
NXF1 to bind segment 7 mRNA [4, 18–20]. To test 
whether the effector domain mutants retained NXF1-
binding activity, 293T cells were transfected with either 
GFP or GFP-NXF1 and 48  h later mock infected or 
infected with the panel of viruses. At 6 h p.i., cells were 
lysed and GFP-Trap precipitations were performed on 
the supernatants. Western blot analyses of total and 
bound fractions showed that GFP and GFP-NXF1 were 
both expressed and collected in comparable amounts 
(Fig.  2a). Blotting for NS1 confirmed successful infec-
tion, although the NS1-E96A/E97A polypeptide again 
accumulated to lower levels than the other NS1s. Never-
theless, all NS1 polypeptides co-precipitated with GFP-
NXF1, indicating that the mutations did not abrogate the 
interaction.
To test whether the effector domain mutations 
affected the ability of NS1 to promote a stable interac-
tion between NXF1 and segment 7 mRNA, 293T cells 
were transfected with GFP or GFP-NXF1 and infected 
with WT or mutant viruses as above. At 6  h p.i., cells 
were lysed and total RNA was extracted before or after 
the lysates had been subjected to GFP-Trap pulldown. 
Segment 7 RNA species were then detected by primer 
extension. Viral mRNAs and genomic RNAs (vRNA) 
were detected in the total fraction of every infected 
sample (Fig.  2b, lanes 1–2 and 4–7). Analysis of the 
bound fraction from WT virus infected cells showed 
that both segment 7 mRNA species but not genomic 
vRNA co-precipitated with GFP-NXF1 (lane 9) while 
no viral RNAs bound to GFP alone (lane 8), consistent 
with previous work [4, 18]. In contrast, viral mRNAs 
were not detected in GFP-NXF1 pulldowns from cells 
infected with either NS1-Y89A or NS1-Y89F viruses 
(lanes 11 and 12). The NS1-W187R and -E96A/E97A 
mutants also supported NXF1 interactions with the 
viral mRNAs (lane 13, 14). Since the E96A/E97A muta-
tion blocked successful nuclear export of segment 7 
mRNA, this finding indicated that, like the interaction 
between NS1 and NXF1, the interaction between NXF1 
and segment 7 is necessary, but not sufficient for the 
successful nuclear export of segment 7 mRNA.
The behaviour of the NS1 E96A/E97A mutant—unable 
to mediate nuclear export of segment 7 mRNA despite 
binding to NXF1 and promoting its interaction with the 
mRNA—suggested the involvement of another essen-
tial factor in the hypothesised ternary export complex. 
Accordingly, we examined cellular interaction partners 
of WT NS1 and the mutants, including a complete dele-
tion of the effector domain (NS1-N81), an RNA-binding 
domain mutant (R38A/K41A) and a gain-of-function 
mutant that restores CPSF30-binding activity (F103S/
M106I), of which only the latter supported mRNA 
nuclear export (Table  1; [4]). 293T cells were trans-
fected with GFP or GFP-tagged NS1 mutant plasmids. 
Two days later, cells were collected, lysed and subjected 
to GFP-Trap. Bound fractions were loaded onto SDS-
PAGE gels and stained with Coomassie Blue. No obvious 
contamination from cellular GFP-binding proteins was 
seen from cells transfected with the GFP control plas-
mid (Fig.  2c, lane 1). Major polypeptide species of the 
expected size were detected in all other samples, includ-
ing the truncated form NS1-N81, confirming successful 
expression (lanes 2–9). Various other minor polypeptide 
species were also visible that were mostly common to all 
NS1-containing samples. However, one clear difference 
was observed; a distinct novel polypeptide in the E96A/
E97A preparation (lane 8) that was absent from other 
samples. LC–MS analysis of the excised band unambigu-
ously identified this polypeptide as heat shock protein 70 
(hsp70) through multiple peptide matches (Additional 
file 1: Table S1).
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To confirm the interaction between NS1-E96A/E97A 
and hsp70, repeat GFP-trap pulldowns were analysed by 
western blotting for hsp70 as well as for the GFP-tagged 
“bait” proteins. Transfection was confirmed by the detec-
tion of GFP and GFP-tagged NS1 mutant proteins, while 
equivalent amounts of hsp70 in the total fractions of all 
samples confirmed that comparable amounts of cell lysates 
had been generated (Fig.  2d, lanes 1–9). However, in the 
bound fraction, hsp70 was detected only in the NS1-E96A/
E97A sample (lane 17), confirming the specific interaction 
with hsp70 for NS1 E96A/E97A.
Discussion
The data reported here extend our previous investi-
gation [4] into the role of NS1 in facilitating nuclear 
export of viral mRNA. Firstly, we show that higher order 
multimerization of NS1 via its effector domain is not 
needed for viral mRNA nuclear export. Secondly, the 
finding that point mutations in the NS1 effector domain, 
and not just its complete deletion along with the C-ter-
minal unstructured region [4], can block viral mRNA 
nuclear export, strengthens the argument for the func-
tional involvement of this domain in the process. Thirdly, 
identification of an NS1 mutant (E96A/E97A) that still 
binds NXF1 and enhances its interaction with segment 7 
mRNA without upregulating mRNA nuclear export sug-
gests that at least one other factor is needed for export. 
Finally, the effect of mutations previously considered 
to specifically inhibit PI3K activation or inhibition of 
retinoic acid-inducible gene I (RIG-I) signalling on M1 
mRNA localisation could suggest the involvement of one 
or both of these pathways in viral mRNA nuclear export.
Fig. 2 Interactions between NS1, cellular proteins and segment 7 mRNAs. a 293T cells were transfected with plasmids encoding GFP or GFP-NXF1 
and 48 h later either mock infected or infected with the indicated NS1 mutant viruses at an M.O.I. of 5. Cells were harvested at 6 h p.i. and cell lysates 
examined by western blotting for the indicated proteins before (total) or after (bound) being subjected to GFP-Trap pulldown assays. b 293T cells 
were transfected with GFP-NXF1 (GFP-NXF1+) or with GFP alone (GFP-NXF1−) and 48 h later either mock infected or infected with the indicated 
viruses at an M.O.I. of 10, in duplicate sets. At 6 h p.i., cells were harvested and total cellular RNA was extracted from one set while the second set 
was subjected to GFP-Trap pulldown assays prior to total RNA extraction. RNA was analysed by reverse transcription with radiolabelled primers 
specific for segment 7 RNAs followed by urea-PAGE and autoradiography. c, d 293T cells were transfected with either GFP alone or with GFP-tagged 
NS1 mutant protein expressing plasmids as indicated and 48 h later cells were harvested and subjected to GFP-Trap pull down assays. Eluted 
samples were loaded onto SDS-PAGE gels and c stained with Coomassie Blue dye or d western blotted for GFP or hsp70 before (totals) or after 
(bound) GFP-trap fractionation. Lanes 1–3 and 8–10 from a are reproduced with permission from Figure 7 of [4]
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Of broader significance than the mechanism of IAV 
mRNA nuclear export, our data add to the evidence 
suggesting pleiotropic effects from NS1 mutations com-
monly used as tools to interrogate viral interactions 
with the PI3K and RIG-I pathways (e.g. [10, 17, 21–28]). 
Potential pleiotropic effects of the E96A/E97A mutation 
have been noted previously, including poor expression 
of the polypeptide as seen here [25] and an intriguing 
effect on PI3K activation [29]. Indeed a recent report 
detailing the crystal structure of NS1-Trim25 complexes 
concluded that NS1 residues E96 and 97 do not directly 
contact Trim25 but instead support a network of contacts 
within the local region of the effector domain in which 
L95 and S99 actually make contact with Trim25 [30]. Our 
finding that the E96A/E97A mutation also induces bind-
ing of hsp70 further suggests effects on protein folding 
and that interpreting results obtained with this mutation 
may be complicated.
Limitations
Attempts to probe the role of PI3K activation in IAV 
mRNA export using small molecule inhibitors gave 
inconsistent results (data not shown) and could not be 
further pursued because of time and funding constraints. 
It would also have been interesting to test the effects of 
hsp70 inhibitors [31] had time allowed. The effect of NS1 
mutations L95A/S99A on mRNA export should also be 
tested.
Additional file
Additional file 1: Table S1. Mascot search results from LC-MS analysis of 
the novel polypeptide band in lane 8 of Fig. 2c. The data include a sum-
mary of protein IDs followed by details on the individual peptide hits.
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